Maven Income and Growth VCT 3 PLC

Maven Income and Growth VCT 3 PLC operates as a venture capital trust, primarily focusing on providing development capital and backing early-stage ventures. For private enterprises, its preference leans towards more mature, later-stage investment opportunities. The fund explicitly avoids participating in hostile public-to-private takeovers. Its core objective is to generate substantial long-term capital growth, principally by investing in smaller, high-potential unlisted and AIM-listed companies based in the United Kingdom. Annually, it allocates a maximum of £1 million (or $1.65 million) to any single company, ensuring that no more than 15% of its total assets (at cost) are committed to one enterprise at any given time. The trust typically aims to secure a Non-Executive Board position within the companies it backs. In instances of larger transactions, co-investment is an option it considers.

Maven Income and Growth VCT 3 PLC trades as MIG3.L on LSE. The company is classified in Financial Services / Asset Management - Income and reports in GBP.

The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £3.36M of revenue and £1.22M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Maven Income and Growth VCT 3 PLC can be compared against peers such as Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund GBP Acc, Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund GBP Inc, Vanguard LifeStrategy 40% Equity Fund A Acc, Vanguard LifeStrategy 40% Equity Fund A Inc, Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund Institutional Plus GBP Acc, Vanguard FTSE Developed Europe ex-U.K. Equity Index Fund Institutional Plus GBP Inc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £68.37M, beta of -0.00, and return on equity of +1.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

MIG3.L currently shows total debt of £0 and beta of -0.00. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.mavencp.com/investment-opportunities/venture-capital-trusts/maven-income-and-growth-vct-3

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.